Skip to main content
. 2025 Dec 8;30(1):5. doi: 10.1007/s10151-025-03242-z

Table 2.

Articles included in the systematic review

Study ID Intervention Design Population Terminology Number (IBD only) Follow-up period Healing rate NIH assessment Medical therapy at time of intervention
Lansdorp 2020 [22] HBOT (40 sessions, 2.4 atm) Prospective case series CD Perineal metastatic CD 3 3 months 33% Fair All patients had prior biologic treatment. No patients on biologics at the time of treatment
Lubbers 1982 [31] Curettage/laying open of tracts/excision of tracts Retrospective case series Mixed Healed/unhealed/persistent sinus 11 Not clearly defined 64% Poor 28.6 had steroid therapy at time of proctectomy. None reported at time of intervention for PPS
Scammell 1986 [32] Multiple procedures (flap, local excision, fibrin glue) Retrospective case series CD Delayed/unhealed wound/PPS 21 Not clearly defined 41.7% Poor 30% had steroid at time of proctectomy. None reported at time of intervention for PPS
Kirkegaard 1983 [21] Fibrin glue Retrospective case series Mixed Perineal sinus 9 Average 3 months (0–5) 89% Poor Not reported
Ambrose 1988 [20] Fibrin glue Retrospective case series Mixed PPS 10 Average 22 months 30% Poor Not reported
Kurtz 2011[26] Rh PDGF application Retrospective case series Mixed Poor/delayed/unhealed wounds 10 Not clearly reported 60%, 100% after second procedure Fair Not reported
Yamamoto 1999 [33]

Multiple procedures (drainage, radical excision with coccygectomy, flaps, omentoplasty

(classification)

Retrospective case series CD Early/delayed healing/PPS 33 157 months (1–275 months) 29% for radical excision and closure, 50% for RAM flap and 50% for omentoplasty Poor 49% had steroid at time of proctectomy. None reported at time of intervention for PPS
Lohsiriwat 2008 [30] Multiple interventions, 11 curettage, 6 VAC, 3 sinus excision, 3 lay open, 2 laparotomy, 1 gracilis flap Retrospective case series Mixed PPS 14 At least 6 months 64% Fair 31% had immunosuppressive therapy at time of pouch excision, 43% at time of intervention for PPS
Branagan 2006 [24] Modified cleft closure Retrospective case series Mixed PPS 5 Mean 43.9 months (range 6—79 months) 80% (one patient requiring repeat procedure Poor Not reported
Au 2016 [39] Karydakis flap Retrospective case series CD PPS 2 Average 12 months 100% Poor Not reported
Yamamoto 2001 [25] Omentoplasty Retrospective case series CD PPS 6 28 months (23–32) 83.3% Poor Not reported
Anderson 1976 [28] Skin grafting Retrospective case series Mixed Unhealed wound 48 Not clearly reported 91% “good”, of which 15% were “completely healed” Poor Corticotropin (ACTH) administered to all patients until discharge
Oakley 1985 [29] Curettage/excision and skin grafting Retrospective case series UC Unhealed wound/delayed healing 35 Not clearly defined 61% Poor Not reported
McLeod 1985 [27] Split-thickness skin grafting Retrospective case series Mixed Chronic perineal sinus 9 Average 55 months (5–12 years) 87.5% Poor Not reported
Bartholdson 1975 [17] Gracilis muscle transposition Retrospective case series Mixed PPS 4 3 months 50% Poor Not reported
Lens 1979 [15] Gracilis muscle flap Retrospective case series Mixed Delayed wound healing/unhealed wound/PPS 3 average 9 months 67% Poor Not reported
Baek 1981 [13] Gracilis muscle flap Retrospective case series Mixed Unhealed wound/PPS 5 8 months 100% Poor Not reported
Anthony 1990 [14] Gracilis and gluteus maximus flap (classification) Retrospective case series Mixed Delayed/nonhealing/chronic wounds 5 Average 3.5 years 100% Poor Not reported
Loessin 1995 [18] Inferiorly based trans-pelvic rectus abdominis muscle or musculocutaneous flap Retrospective case series UC/CD ? mixed Persistent perineal/sacral defects 4 Average 32 (6–56)

100%

(75% “excellent, 25%

“fair”)

Poor 80% had immunosuppressive treatment
Rius 2000 [16] Gracilis muscle flap Retrospective case series CD Unhealed wound/PPS 3 18 months 100% Poor 66% of patients had previous steroid therapy
Maeda 2011 [40] Gracilis muscle flap Retrospective case series CD Persistent non-healing perianal sinus/non-healing perineum 4 Average 64 months (23–123) 75% (healed unhealed) Fair No patients on medical therapy
Chan 2014 [12] RAM flap and perioperative HBOT Retrospective case series Mixed PPS 4 Average 35 months (8–64) 100% Fair 25% of patients had previous infliximab therapy

ACTH adrenocorticotropic hormone, CD Crohn’s disease, HBOT hyperbaric oxygen therapy, IBD inflammatory bowel disease, PPS persistent perineal sinus, RAM rectus abdominis muscle, Rh PDGF recombinant human platelet-derived growth factor, UC ulcerative colitis, VAC vacuum-assisted closure